KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Petmed Express (PETS) over the last 16 years, with Q4 2025 value amounting to $3.3 million.

  • Petmed Express' Other Working Capital Changes rose 132875.54% to $3.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.7 million, marking a year-over-year increase of 16274.08%. This contributed to the annual value of -$995000.0 for FY2025, which is 2989.56% down from last year.
  • Latest data reveals that Petmed Express reported Other Working Capital Changes of $3.3 million as of Q4 2025, which was up 132875.54% from -$2.3 million recorded in Q3 2025.
  • Petmed Express' 5-year Other Working Capital Changes high stood at $3.3 million for Q4 2025, and its period low was -$3.4 million during Q1 2024.
  • In the last 5 years, Petmed Express' Other Working Capital Changes had a median value of $82500.0 in 2021 and averaged $34250.0.
  • In the last 5 years, Petmed Express' Other Working Capital Changes surged by 1843333.33% in 2022 and then tumbled by 105306.12% in 2025.
  • Petmed Express' Other Working Capital Changes (Quarter) stood at -$1.2 million in 2021, then surged by 114.73% to $174000.0 in 2022, then tumbled by 589.66% to -$852000.0 in 2023, then soared by 127.35% to $233000.0 in 2024, then soared by 1328.76% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q4 2025, -$2.3 million for Q3 2025, and $1.2 million during Q2 2025.